Risk stratification of patients undergoing medical therapy after coronary angiography

Eur Heart JPublished Secondary analysis of the ACUITY randomised trial

Authors' conclusion

In patients with NSTE ACS undergoing medical therapy, the SS, especially when >8, was shown to be a strong predictor of 1-year MACE, including mortality.

Study context

Population
Patients with NSTE ACS undergoing coronary angiography treated with medical therapy onlyof 4491 medically treated
Participants
1,275 patients
Comparison
SYNTAX score categories in medically treated NSTE ACS
  • SS 0n = 842reference
  • SS >0 and ≤5n = 170
  • SS >5 and ≤11n = 119
  • SS >11n = 144
Primary endpoint
MACE:
  • Death
  • MI
  • Unplanned revascularization
Follow-up
1 year

Primary result

As reported in the abstract

MACE

SS cut-off with best prognostic accuracy for death and major adverse cardiac events (MACE) (ROC)

8

Further findings

SYNTAX score

Mean SS
3.5 ± 7.0 (range 0-45)

Original publication

Risk stratification of patients undergoing medical therapy after coronary angiography. Eur Heart J. Published 18 December 2015. doi:10.1093/eurheartj/ehv674

Summarised from the published abstract; every number is checked against it

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.